| Application no. and date | 19845343.3 (espacenet) (Federated) (European Patent Register), 20190729 | | Patent/reg. no. and date | DK/EP 3829551, 20240103 | | Publication date | 20210609 | | Priority no. and date | US 201862711936 P, 20180730, US 201862731442 P, 20180914 | | EP pub. no. and date |
EP 3829551 20210609 | | Effective date | | | Applicant/owner | Biothea Pharma, Inc., 2 Avery Street
Suite 21E
Boston, MA 02111, US | | Applicant ref. no. | | | Inventor | SOMMADOSSI, Jean-Pierre, 2 Avery Street 21 E
Boston, Massachusetts 02110, US,
MOUSSA, Adel, 9 Chandler Road
Burlington, Massachusetts 01803, US | | Representative | | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/137 (2006.01) , A61K 47/12 (2006.01) , C07C 215/60 (2006.01) , C07C 55/08 (2006.01) | | Title | CRYSTALLINE EPINEPHRINE MALONATE SALT | | Int. application no. | US2019043856 | | Int. publication no. | WO2020028215 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
